Pages that link to "Q53058993"
Jump to navigation
Jump to search
The following pages link to FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion. (Q53058993):
Displaying 10 items.
- The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics (Q26795601) (← links)
- Transcriptomic and Functional Pathway Analysis of Human Cervical Carcinoma Cancer Cells Response to Microtubule Inhibitor (Q35978565) (← links)
- Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells (Q36254216) (← links)
- TWEAK/Fn14 signaling in tumors (Q38668064) (← links)
- Kruppel-like factor 4 inhibits non-small cell lung cancer cell growth and aggressiveness by stimulating transforming growth factor-β1-meidated ERK/JNK/NF-κB signaling pathways (Q38717810) (← links)
- The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion (Q38940817) (← links)
- A Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis (Q41523753) (← links)
- TWEAK promotes migration and invasion in MEFs through a mechanism dependent on ERKs activation and Fibulin 3 down-regulation (Q48312410) (← links)
- Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells (Q87444618) (← links)
- Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B (Q99594107) (← links)